Characterization of γ-aminobutyric acid type A receptor-associated protein, a novel tumor suppressor, showing reduced expression in breast cancer

Cancer Research

Volumn 65, Issue 2, 2005, Pages 394-400

  Klebig, Christiane ^a   Seitz, Susanne ^b   Arnold, Wolfgang ^c   Deutschmann, Nicole ^a   Pacyna Gengelbach, Manuela ^a   Scherneck, Siegfried ^b   Petersen, Iver ^a,d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c Atugen AG   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; GAMMA AMINOBUTYRIC ACID A RECEPTOR ASSOCIATED PROTEIN; MESSENGER RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST; BREAST CANCER; CANCER GENETICS; CANCER GROWTH; CARCINOGENICITY; COLONY FORMATION; CPG ISLAND; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYBRID CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTRADUCTAL CARCINOMA; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; TRANSPORT VESICLE; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AZACITIDINE; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBCELLULAR FRACTIONS; TRANSFECTION; UP-REGULATION;

EID: 12544249306     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Hoff C, Mollenhauer J, Waldau B, Hamann U, Poustka A. Allelic imbalance and fine mapping of the 17p13.3 subregion in sporadic breast carcinomas. Cancer Genet Cytogenet 2001;129:145-9.
2. Phillips N, Ziegler M, Saha B, Xynos F. Allelic loss on chromosome 17 in human ovarian cancer. Int J Cancer 1993;54:85-91.
3. Konishi H, Takahashi T, Kozaki K, et al. Detailed deletion mapping suggests the involvement of a tumour suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancer. Oncogene 1998;17:2095-100.
4. Piao Z, Park C, Park JH, Kim H. Allelotype analysis of hepatocellular carcinoma. Int J Cancer 1998;75:29-33.
5. Seitz S, Poppe K, Fischer J, et al. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters. J Pathol 2001;194:318-26.
6. Theile M, Hartmann S, Scherthan H, et al. Suppressor of tumorigenicity of breast cancer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes. Oncogene 1995;10:439-47.
7. Bálint É, Vousden KH. Activation and activities of the p53 tumour suppressor protein. Br J Cancer 2001;85:1813-23.
8. Makos Wales M, Biel MA, El Deiry W, et al. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med 1995;1:570-7.
9. Bruening W, Prowse AH, Schultz DC, Holgado-Madruga M, Wong A, Godwin AK. Expression of OVCAI, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells. Cancer Res 1999;59:4973-83.
10. Zhao X, Li J, He Y, et al. A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma. Cancer Res 2001;61:7383-7.
11. A receptors and the cytoskeleton. Nature 1999;397:69-72.
12. Green F, O'Hare T, Blackwell A, Enns CA. Association of human transferrin receptor with GABARAP. FEBS Lett 2002;518:101-6.
13. Saxon PJ, Srivatsan ES, Leipzig GV, Sameshima JH, Stanbridge EJ. Selective transfer of individual human chromosomes to recipient cells. Mol Cell Biol 1985;5:140-6.
14. Yang X, Tahin Q, Hu YF, et al. Functional roles of chromosomes 11 and 17 in the transformation of human breast epithelial cells in vitro. Int J Oncol 1999;15:629-38.
15. Petersen S, Heckert C, Rudolf J, et al. Gene expression profiling of advanced lung cancer. Int J Cancer 2000;86:512-7.
16. Chen Y, Hühn D, Knösel T, Pacyna-Gengelbach M, Deutschmann N, Petersen I. Downregulation of connexin 26 in human lung cancer is related to promoter methylation. Int J Cancer. In press 2004.
17. Chen Y, Petersen S, Pacyna-Gengelbach M, Pietas A, Petersen I. Identification of a novel homeobox-containing gene, LAGY, which is downregulated in lung cancer. Oncology 2003;64:450-8.
18. Pietas A, Schlüns K, Marenholz I, Schafer BW, Heizmann CW, Petersen I. Molecular cloning and characterization of the human S100A14 gene encoding a novel member of the SI00 family. Genomics 2002;79:513-22.
19. Theile M, Hartmann S, Naundorf H, et al. Wild-type p53 is not involved in reversion of the tumorigenic phenotype of breast cancer cells after transfer of normal chromosome 17. Int J Oncol 1994;4:1067-75.
20. A receptor-associated protein. Genomics 2001;74:408-13.
21. A receptor interaction. J Neurochem 2000;75:644-55.
22. A receptor clustering and modulates the channel kinetics. Proc Natl Acad Sci U S A 2000;97:11557-62.
23. Kneussel M, Brandstatter JH, Laube B, Stahl S, Muller U, Betz H. Loss of postsynaptic GABA(A) receptor clustering in gephyrin-deficient mice. J Neurosci 1999;19:9289-97.
24. AR)-associated protein GABARAP interacts with gephyrin but is not involved in receptor anchoring at the synapse. Proc Natl Acad Sci U S A 2000;97:8594-9.
25. A receptors. Mol Cell Neurosci 2001;18:13-25.
26. Paz Y, Elazar Z, Fass D. Structure of GATE-16, membrane transport modulator and mammalian ortholog of autophagocytosis factor Aut7p. J Biol Chem 2000;275:25445-50.
27. Lang T, Schaeffeler E, Bernreuther D, Bredschneider M, Wolf DH, Thumm M. Aut2p and Aut7p, two novel microtubule-associated proteins are essential for delivery of autophagic vesicles to the vacuole. EMBO J 1998;17:3597-607.
28. Rothman JE. Mechanisms of intracellular protein transport. Nature 1994;372:55-63.
29. Nemos C, Mansuy V, Vernier-Magnin S, Fraichard A, Jouvenot M, Delage-Mourroux R. Expression of gec1/ GABARAPL1 versus GABARAP mRNAs in human: predominance of gec1/GABARAPL1 in the central nervous system. Brain Res Mol Brain Res 2003;119:216-9.
30. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
31. Sorkin A, Waters CM. Endocytosis of growth factor receptors. BioEssays 1993;15:375-82.
32. Wells A, Welsh JB, Lazar CS, Wiley HS, Gill GN, Rosenfeld MG. Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. Science 1990;247:962-4.
33. Sakamuro D, Elliot KJ, Wechsler-Reya R, Prendergast GC. BIN1 is a novel MYC-interacting protein with features of a tumour suppressor. Nat Genet 1996;14:69-77.
34. Dreyling MH, Martinez-Climent JA, Zheng M, Mao J, Rowley JD, Bohlander SK. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. Proc Natl Acad Sci U S A 1996;93:4804-9.
35. Sager R. Expression genetics in cancer: shifting the focus from DNA to RNA. Proc Natl Acad Sci U S A 1997;94:952-5.
36. Wiechen K, Diatchenko L, Agoulnik A, et al. Caveolin-1 is downregulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol 2001;159:1635-43.
37. Bachmann KE, Park BH, Rhee I, et al. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 2003;3:89-95.
38. Mielnicki LM, Ying AM, Head KL, Asch HL, Asch BB. Epigenetic regulation of gelsolin expression in human breast cancer cells. Exp Cell Res 1999;249:161-76.
39. Maass N, Biallek M, Rosel F, et al. Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer. Biochem Biophys Res Commun 2002;297:125-8.